Amneal Pharmaceuticals Inc (AMRX)

01:38 AM

Here's why Amneal Pharmaceuticals (AMRX) is a strong growth stock - MSN

01:38 AM

12:59 PM

Amneal Pharmaceuticals (AMRX) is a top-ranked momentum stock: Should you buy? - MSN

12:59 PM

12:45 PM

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

12:45 PM

10:27 AM

AMRX: 3 growth drivers behind Amneal's 2026 outlook - MSN

10:27 AM

09:55 AM

Wall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High? - Yahoo Finance

09:55 AM

09:40 AM

Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now? - Yahoo! Finance Canada

09:40 AM

06:17 AM

Here's how AMRX is tapping GLP-1 demand through manufacturing - MSN

06:17 AM

04:02 AM

AMRX Should I Buy - Intellectia AI

04:02 AM

01:39 AM

Amneal to buy Kashiv in $750M deal; raises FY26 EPS outlook - MSN

01:39 AM

Apr 28, 2026

AMRX growth drivers: Generics, biosimilars, and Crexont - MSN

Apr 28, 2026

Apr 28, 2026

Amneal to Ring the Nasdaq Closing Bell on April 2, 2024 - Quantisnow

Apr 28, 2026

Apr 28, 2026

Amneal 2026-2027 Upside From Biosimilars Scale - Zacks Investment Research

Apr 28, 2026

Apr 28, 2026

AMRX Valuation: What 1.69x Sales Means for Investors - Yahoo Finance

Apr 28, 2026

Apr 28, 2026

AMRX Growth Drivers: Generics, Biosimilars, and Crexont - Yahoo Finance Australia

Apr 28, 2026

Apr 27, 2026

BlackRock (NYSE: AMRX) holds 24.1M shares, 7.6% stake reported - Stock Titan

Apr 27, 2026

Apr 27, 2026

Amneal Pharma to acquire Kashiv BioSciences to create fully integrated global biosimilar leader - MSN

Apr 27, 2026

Apr 27, 2026

Here's Why Amneal Pharmaceuticals (AMRX) is a Strong Growth Stock - Yahoo Finance

Apr 27, 2026

Apr 26, 2026

Amneal initiates nationwide settlement for opioid-related claims - MSN

Apr 26, 2026

Apr 26, 2026

Why Amneal Pharmaceuticals (AMRX) is a top growth stock for the long term - MSN

Apr 26, 2026

Apr 26, 2026

Amneal rated buy in new research coverage at UBS as growth pipeline expands - MSN

Apr 26, 2026

Apr 25, 2026

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Strong Multi Year Returns And Recent Share Price Cooldown - Yahoo Finance

Apr 25, 2026

Apr 25, 2026

Amneal Kashiv Deal Shifts Biosimilar Growth And Valuation Story - Sahm

Apr 25, 2026

Apr 24, 2026

UBS initiates coverage of Amneal Pharmaceuticals (AMRX) with buy recommendation - MSN

Apr 24, 2026

Apr 24, 2026

Amneal anticipates deleveraging below 3x by 2028 as it outlines $4.3B-$4.5B 2030 revenue target following Kashiv deal - MSN

Apr 24, 2026

Apr 24, 2026

Amneal Acquires Kashiv BioSciences for $750 Million Upfront - HarianBasis.co

Apr 24, 2026

Apr 24, 2026

Amneal Pharmaceuticals to Buy Kashiv BioSciences, Touts Strong Preliminary Q1 Results and Biosimilar Push - MarketBeat

Apr 24, 2026

Apr 24, 2026

AMRX Price Today: Amneal Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026

Apr 23, 2026

2DT Stock Price and Chart — TRADEGATE:2DT - TradingView

Apr 23, 2026

Apr 23, 2026

Why Is Amneal Pharmaceuticals Stock Gaining Today? - Sahm

Apr 23, 2026

Apr 23, 2026

AMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary Results - The Globe and Mail

Apr 23, 2026

Apr 23, 2026

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Apr 23, 2026

Apr 23, 2026

Amneal agrees to buy Kashiv BioSciences - The Pharma Letter

Apr 23, 2026